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This review considers the emerging relationships between environmental factors and epi-
genetic alterations and the application of genome-wide assessments to better deﬁne these
relationships. First we will brieﬂy cover epigenetic programming in development, one-
carbonmetabolism, and exposures thatmay disrupt normal developmental programming of
epigenetic states. In addition, because a large portion of epigenetic research has focused on
cancer, we discuss exposures associated with carcinogenesis including asbestos, alcohol,
radiation, arsenic, and air pollution. Research on other exposures that may affect epigenetic
states such as endocrine disruptors is also described, and we also review the evidence for
epigenetic alterations associated with aging that may reﬂect cumulative effects of expo-
sures. From this evidence, we posit potential mechanisms by which exposures modify
epigenetic states, noting that understanding the true effect of environmental exposures
on the human epigenome will require additional research with appropriate epidemiologic
studies and application of novel technologies.With amore comprehensive understanding of
the affects of exposures on the epigenome, including consideration of genetic background,
the prediction of the toxic potential of new compounds may be more readily achieved, and
may lead to the development of more personalized disease prevention and treatment
strategies.
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INTRODUCTION
Epigenetics can be broadly deﬁned as mitotically and meiotically
heritable changes in gene expression and gene expression potential
that cannot be explained by changes in DNA sequence. Exam-
ples of epigenetic states that can be altered include methylation
of cytosine residues on DNA, post-translational modiﬁcation of
histone tails, and microRNA (miRNA) expression. DNA methy-
lation is the most widely studied epigenetic mark and refers to
the catalytic addition of a methyl group to the ﬁfth carbon posi-
tion of a cytosine residue that is followed on the same strand by
guanine, also known as a CpG dinucleotide. Though underrepre-
sented in the genome, CpG dinucleotides occur in concentrations
known as CpG-islands, and CpG-islands can be found in the
promoter region of approximately half of all human genes. In
pathologically normal cells promoter CpG-island regions are typ-
ically unmethylated. Aberrant methylation of a CpG-island can
result in gene silencing, and this is awell-recognizedmechanismby
which epigenetic alterations can contribute to a disease phenotype.
Epigenetic regulatory mechanisms are stable mechanisms for
the control of gene expression, though they also display some level
of plasticity, likely in response to various cues from the environ-
ment. Thus, it is increasingly important to characterize the role
for environmental exposures in epigenetic alterations. Much of
the existing evidence implicating a role of environmental fac-
tors on the epigenome comes from studies of disease outcomes
such as cancer and adverse reproductive/developmental events,
although there is a growing literature in the role of the psychoso-
cial environment’s impact on the epigenome as well. Initially,
epigenetic alterations were identiﬁed in various human tumors
and consequently, environmental exposures to toxicants known to
have an etiologic role in cancer such as air pollutants, and metals
have been studied and implicated in themodiﬁcation of epigenetic
marks in pathologic tissues.
To better understand the importance and function of such
alterations in disease states, we might begin to consider how envi-
ronmental factors may inﬂuence the epigenome in pathologically
normal tissues, perhaps representing alterations necessary to ini-
tiate or predispose to disease phenotypes. To date, the majority
of epigenetic research in human studies has focused on DNA
methylation, though emerging work is beginning to address the
affect of environmental exposures on histone modiﬁcations and
miRNA expression. This review highlights the current evidence
that epigenetic alterations are associatedwith environmental expo-
sures, focusing on human studies, and considers through this
research thepotentialmechanismsbehind environmentally related
epigenetic alterations.
DEVELOPMENT AND EPIGENETIC PROGRAMMING
The establishment of somatic cell epigenetic patterns, in mam-
mals, occurs early in fetal development. The re-establishment of
appropriate epigenetic patterns is subsequent to genome-wide de-
methylation following fertilization, required for allowing totipo-
tency and pluripotency dynamics (Morgan et al., 2005). Thus,
embryonic and fetal development represent a critical period dur-
ing which nutrient availability as well as environmental stressors,
including toxicant exposures, have great potential to affect the epi-
genetic reprogramming and patterning phenomena. Thus, these
effects can not only have implications for proper development,
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but perhaps even life-long conditioning and health (Li, 2002;
Gluckman et al., 2008). For instance, it is well-known that folate
deﬁciency is associated with neural tube defects (NTD; Daly et al.,
1995), animal studies have indicated the necessity of sufﬁcient
methyl group availability for proper neural tube development
(Dunlevy et al., 2006), and hypomethylation of long interspersed
nucleotide elements (LINE) and genomic DNA has been associ-
ated with increased risk of NTDs in humans (Wang et al., 2010).
Beyond birth, though, epigenetic mechanisms may contribute
to the developmental origins of health and disease hypothesis
(Waterland and Michels, 2007), which links nutritional and envi-
ronmental stimuli at critical developmental periods (pre- and
post-natal) to susceptibility for various health outcomes through-
out life, including metabolic and chronic diseases (Gluckman and
Hanson, 2004).
The importance of folate, and other nutrients involved in one-
carbon metabolism on the establishment and maintenance of
DNA methylation and potentially other epigenetic mechanisms
is one mode through which toxicants may have epigenome-wide
effects. One-carbon metabolism is the network of biochemical
reactions essential to both DNA synthesis and all cellular bio-
molecule (nucleic acids, proteins, lipids) methylation reactions
that involve the transfer of one-carbon groups. Folate (vitamin
B9), a central nutrient in this pathway, donates its methyl group
for homocysteine remethylation to methionine. Subsequently,
methionine is the methyl donor for all cellular methylation reac-
tions, most notable for this discussion being DNA and histone
methylation via S-adenosyl-methionine (SAM), and other B vita-
mins (B2, B6, B12) that act as enzymatic cofactors in the network.
Collectively,B vitamins,homocysteine,andmethionine are impor-
tant contributors to the maintenance of DNA integrity and DNA
methylation. The one-carbon pathway links nutrient availability
with not only DNA methylation, but also with toxicant metabo-
lism through glutathione and the glutathione transferase (GST)
enzyme family (Figure 1). Therefore, interactions between one-
carbon pathway participants may modify associations between
exposures, pathway participants, and methylation alterations. In
fact, a study of reduced GST enzyme activity in a mouse model of
Alzheimer’s disease and neuronal health has shown that SAM can
mediate the activity of GST enzymes (Tchantchou et al., 2008).
This suggests that reactions dependent upon SAM are necessary
for GST activity and that SAM may be a critical mediator of
neuronal health (Tchantchou et al., 2008). Furthermore, it could
be predicted that GST enzyme family genotypes (among other
genotypes) will be shown to modify associations between certain
exposures and DNA methylation alterations. Hence integrative
studies that incorporate genetics (genotype and/or alterations)
with measures of epigenetic alterations will allow a more compre-
hensive understanding of the relation among exposures, epigenetic
alterations, and genetic states.
The key role of one-carbon metabolism also brings to light
the potential risks of high-dose nutrient supplementation prac-
tices. Folate supplementation is associated with a reduced risk of
many forms of cancer, though once disease is present it is pos-
sible that a relative increase in one-carbon nutrient levels may
speed disease progression or invasiveness dependent upon the
epigenetic character of the disease state. Some evidence for this
FIGURE 1 |The relationships among metabolic components involved
in one-carbon metabolism and important for DNA synthesis, DNA
methylation, and toxicant metabolism. Enzymes that participate in
metabolic reactions appear italicized in blue. Metabolic component
abbreviations: tetrahydrofolate (THF), dihydrofolate (DHF),
S-adenosyl-methionine (SAM), S-adenosyl-homocysteine (SAH).
potential comes from our recent study of breast tumor methy-
lation where increased folate intake (controlling for potential
confounders) was associated with a methylation proﬁle that was
independently associated with increased tumor size (Christensen
et al., 2010). Excessive folate supplementation may have poten-
tial adverse effects including masking of B12deﬁciency, disruption
of zinc function, or interfering with one-carbon homeostasis and
additional study is required to elucidate these potential effects
(Hathcock, 1997; Sauer et al., 2009). In addition, more research is
needed to ascertain best practices for assessing folate/methyl avail-
ability, perhaps comparing food-frequency-questionnaire data to
homocysteine and/or SAM/SAH levels in a prospective manner.
TOXICANTS AND EPIGENETIC ALTERATIONS
ALCOHOL
Alcohol is known to interfere with folate absorption in the intes-
tine and hepatic release of folate, and hence, supply to tissues
(Hillman and Steinberg, 1982) and thus it too can be consid-
ered a toxicant with the potential for epigenomic alteration. More
speciﬁcally, through interference with several steps of methionine
metabolism alcohol can lead to activation of betaine homocysteine
methyltransferase thereby activating a compensatory pathway for
maintenance of SAM levels (Kharbanda, 2009). Continuous expo-
sure though, can overload the compensatory pathway and result
in liver injury. In addition to liver injury, an etiologic role for
alcohol in several cancers is well established (International Agency
for Research on Cancer, 1988). Alcohol consumption increases
colon cancer risk (Giovannucci et al., 1995), though the asso-
ciation may be modiﬁed by dietary folate, and may be speciﬁc
to LINE-1 hypomethylated tumors (Schernhammer et al., 2010).
More speciﬁcally, subjects with high folate intake were less likely to
develop LINE-1 hypomethylated colon cancers but subjects with
high alcohol consumption had a signiﬁcantly increased risk of
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developing LINE-1 hypomethylated colon cancers with no associ-
ation for more highly methylated LINE-1 tumors (Schernhammer
et al., 2010). In addition, in head and neck squamous cell carci-
noma, where alcohol has a well-recognized etiologic role, alcohol
consumptionhas been signiﬁcantly associatedwith reducedLINE-
1 methylation (Smith et al., 2007). Proﬁles of DNA methylation
in HNSCC tumors are signiﬁcantly and independently associated
with alcohol intake (Marsit et al., 2009), suggesting that alcohol
usemay drive or select for the epigenetic alteration of speciﬁc gene
regions. Inmultiplemeta-analyses of prospective and case–control
studies of breast cancer, a 10% excess risk for each alcoholic drink
per day has been reported (Hamajima et al., 2002; Key et al., 2006).
A study of breast tumor DNA methylation proﬁles demonstrated
a signiﬁcant, independent association (controlling for age, dietary
folate,andother variables) between alcohol intake and tumorDNA
methylation proﬁle (based on 1413 CpG loci; Christensen et al.,
2010). In addition toDNAmethylation, ethanol exposure has been
shown to selectively acetylate histone H3 at lysine 9 (H3K9) in
primary culture of rat hepatocytes (Park et al., 2003) and in rats
in vivo (Kim and Shukla, 2006), though studies in humans are nec-
essary. Collectively, these studies suggest that a major carcinogenic
mechanism of action of alcohol is interference with epigenetic
regulation, in part through disruption of one-carbonmetabolism.
ASBESTOS
Despite the known risks of exposure, asbestos continues to be
mined and exported to developing nations where occupational
exposures can be high.With approximately 80%of cases reporting
a known exposure to asbestos (Robinson and Lake, 2005), asbestos
exposure is the main risk factor for malignant pleural mesothe-
lioma. Importantly, in contrast to tobacco smoke and radiation,
asbestos is known to be a weak mutagen (Sugarbaker et al., 2008),
and there have been several reports of tumor suppressor gene
methylation in mesothelioma (Ohta et al., 1999; Hirao et al., 2002;
Lee et al., 2004; He et al., 2005). In patients with mesothelioma,
Tsou et al. (2007) described a signiﬁcant association between
self-reported asbestos exposure and methylation at the MT1A,
and MT2A gene loci among 28 genes examined. A signiﬁcant
association has been reported between an increasing number of
methylated cell cycle control genes and a quantitative asbestos
burden measure (Christensen et al., 2008). This was followed by
examination using an array-based approach, which demonstrated
that quantitativemeasure of asbestos exposure was associatedwith
over 100 discrete CpG loci, and that in almost all cases (94%)
there was increased methylation associated with increased expo-
sure (Christensen et al., 2009a). Further, overall methylation pro-
ﬁles for mesotheliomas were signiﬁcantly associated with asbestos
exposure burden (Christensen et al., 2009a).
ARSENIC
Arsenic exposure has been associatedwithDNAmethylation alter-
ations in non-pathologic as well as tumor tissues and there is some
data suggesting that changes in miRNA expression and histone
tail modiﬁcations are also associated with exposure to arsenic.
Although the mode (or modes) by which arsenic contributes
to carcinogenesis is not completely clear, there is some specu-
lation that arsenite-generated free radicals and arsenite-generated
reactive oxygen species lead to genotoxic damage (Rossman,2003).
Despite continued speculation on the mechanisms by which
arsenic can contribute to carcinogenesis, in vitro exposures to inor-
ganic arsenic species have been shown to result in altered DNA
methylation (Zhao et al., 1997; Zhong and Mass, 2001).
As more studies are conducted a complex picture of dose-
dependent DNA methylation alterations with arsenic exposure is
beginning to emerge. Chanda et al. (2006) have shown that arsenic
exposure can result in CDKN2A hypermethylation in human
blood DNA, but that a subgroup of cases had hypomethylation
with high arsenic exposure. More recently, a group of some of
the same authors has better quantiﬁed the relation showing that
exposures to 250–500μg/L of arsenic in drinking water results
in global hypermethylation (3H methyl group uptake), but that
>500μg/L of arsenic results in global hypomethylation (Majum-
dar et al., 2010). In human bladder cancer, relatively low levels
of inorganic arsenic exposure has been associated with methy-
lation of RASSF1A and PRSS3 (but not CDKN2A; Marsit et al.,
2006b). A recent study of a large number of human bladder
tumors that examined hundreds of genes demonstrated a rela-
tionship in promoter methylation proﬁles with arsenic exposures,
suggesting that more highly methylated tumors came from indi-
vidualswith larger drinkingwater arsenic exposures, and that these
tumors were more aggressive (Wilhelm-Benartzi et al., 2010). In
mousemodels ofmethyl- or folate-deﬁcient diets, arsenic exposure
through water supply led to hypomethylation in hepatic-derived
DNA (Okoji et al., 2002), as well as to increases in chromoso-
mal aberrations in blood lymphocytes (Mcdorman et al., 2002).
In another study, Pilsner et al. (2007) showed increased DNA
methylation to be associated with urinary and plasma arsenic
and plasma folate, and that the association between arsenic and
methylation was modiﬁed by folate in that it was restricted to
individuals with high plasma folate. This same group has shown
that folic acid supplementation lowers blood arsenic (Gamble
et al., 2007), maternal and cord blood pairs have highly cor-
related arsenic levels (Hall et al., 2007), and folate deﬁciency,
hyperhomocysteinemia, and leukocyte hypomethylation are asso-
ciated with arsenic-induced skin lesions (Pilsner et al., 2009).
Thus, perhaps a more plausible mechanism for arsenic-related
carcinogenicity is via the depletion of S-adenosyl-methionine
(SAM, the universal methyl donor) due to themetabolism of inor-
ganic arsenic to its methylated forms resulting in altered DNA
methylation.
Beyond interfering with one-carbon metabolism and affect-
ing DNA methylation, treatment of human lymphoblastoid cells
with sodium arsenite led to global increases in miRNA expres-
sion (Marsit et al., 2006a). The genotoxic effects of arsenic may
also be mediated by altered chromatin and Ramirez et al. (2008)
have shown in human hepatocarcinoma cells that treatment with
sodium arsenite resulted in global increases in histone acetylation.
Thus, it is reasonable to posit that increased expression of miRNAs
associated with arsenic exposure may be due to increased histone
acetylation. As with other toxicants, additional studies are nec-
essary to further elucidate the associations between arsenic and
all major forms of epigenetic alteration with particular attention
being given to dose and modiﬁcation by one-carbon metabolism
pathway participants.
www.frontiersin.org November 2011 | Volume 2 | Article 84 | 3
Christensen and Marsit Epigenomics in environmental health
OTHER METALS (NICKEL, LEAD, CADMIUM, CHROMIUM)
There is a growing body of evidence for epigenetic alterations
due to exposure to other metals in humans; several studies have
suggested that exposures to metals such as nickel, lead, cad-
mium, and others may alter epigenetic marks. In vitro, nickel
exposure has been associated with various histone modiﬁcation
and decreased histone H4 acetylation (Broday et al., 2000; Ke
et al., 2006). Exposure of a rat cell line to cadmium resulted in
a concentration-dependent reduction in DNA methyltransferase
activity (Takiguchi et al., 2003).
In a study among electric-furnace steel plant workers, experi-
encing metal-rich (lead, cadmium, chromium) particulate matter
exposure has resulted in signiﬁcant alterations of miRNA expres-
sion in peripheral blood leukocytes (Bollati et al., 2010). Patella
lead levels, amongst participants in the Normative Aging Study
were associated with reduced global DNA methylation (LINE-1
elements) though not Alu repeat regions (Wright et al., 2010),
suggesting a role for lead exposure in epigenetic alterations. Inter-
estingly, a sexually dimorphic global methylation (Luminometric
methylation assay for CCGG) level decrease was associated with
brain mercury levels in male polar bears (Pilsner et al., 2010).
The industrial applications of chromium include chrome plat-
ing and stainless steel welding and its exposure amongst those
occupationally exposed as been related to lung cancers (Gibb
et al., 2000). Beyond the recognized role for methylation induced
silencing of CDKN2A in lung cancer that is related to tobacco
smoking (Kim et al., 2001; Toyooka et al., 2003), Kondo et al.
(2006) showed that chromate lung cancersweremore likely to have
methylated CDKN2A with increasing duration of occupational
chromate exposure. An in vitro exposure of mouse hepatoma
cells to chromium showed transcriptional repression of Cyp1a1
by local cross-linking of Hdac and Dnmt1 and altered histone
marks (Schnekenburger et al., 2007). However, additional study
of this diminishing exposure is necessary to validate potential
chromium-induced epigenetic alterations.
PARTICULATES AND AIR POLLUTION
Though few studies have addressed the potential for air pollution
exposure to alter DNA methylation, environmental particulate
exposure has been linked to increased risk of lung cancer and
increased morbidity and mortality from cardiovascular and res-
piratory illnesses (Vineis and Husgafvel-Pursiainen, 2005). In rat
lung cancermodels of tumors induced by diesel exhaust, 59%were
methylated at Cdkn2a, and 14% at Esr1, in those induced by car-
bon black 45%weremethylated atCdkn2a and 14% at Esr1, and in
those induced by berylliummetal strikingly 80% were methylated
at Cdkn2a and 50% at Esr1 (Belinsky et al., 2002), suggesting a
role for epigenetic alteration in the mechanisms of these particu-
lates’ carcinogenicity. A study using primary bronchial epithelial
cells from non-smokers has shown dramatic alterations inmiRNA
expression following treatment with diesel exhaust particles (197
of 313 measured were up or down-regulated more than 1.5 fold),
and suggested that the alterations were associated with inﬂamma-
tory response pathways (Jardim et al., 2009). Signiﬁcantly lower
peripheral blood NOS2 promoter methylation was observed in
steel plant workers with exposure to particulate matter of<10μm
(PM10;Tarantini et al., 2009). In addition, this same study reported
signiﬁcantly reduced methylation of LINE-1 and Alu repeat ele-
ments in blood DNA associated with long-term PM10 exposure
(Tarantini et al., 2009). Consistent with this, a recent report exam-
ining the affect of ambient particulate pollutants on repeat element
methylation in subjects from the Boston area Normative Aging
Study found signiﬁcantly decreased LINE-1methylation following
recent exposure to higher black carbon (Baccarelli et al., 2009).
Ren et al. (2010) found that interquartile range increases in
PM2.5 and black carbon were associated with increases in plasma
homocysteine (part of one-carbon metabolism), and glutathione
(an antioxidant dependent upon homocysteine levels) transferase
theta genotype. This same group of authors has also reported
that increases in mean air pollution PM10 concentrations did not
signiﬁcantly alter fasting or post methionine-load total homo-
cysteine in non-smokers, but was associated with signiﬁcantly
increased homocysteine levels in smokers, suggesting interactions
between exposures may contribute to epigenetic alterations (Bac-
carelli et al., 2007). Another line of evidence for modiﬁcation of
exposure effects on epigenetics by genetics comes from Wilker
et al. (2010) who have reported that increases in black carbon
associated with increased blood pressure are modiﬁed by SNPs in
miRNA processing machinery genes such as DICER and GEMIN
genes.
ENDOCRINE DISRUPTORS
Exposures to endocrine disrupting chemicals such as the model
toxicant diethylstilbestrol (DES) and the omnipresent bisphenol
A (BPA) are of particular concern in the context of development.
In utero exposure of mice to DES has been shown to result in
the hypermethylation of the developmentally critical (speciﬁcally
to uterine organogenesis) Hoxa10 gene (Bromer et al., 2009).
Although not a genotoxic agent, epidemiologic evidence from
individuals exposed to DES during the ﬁrst 3months in utero
indicates an increase in vaginal clear cell carcinoma incidence and
reproductive disorders as adults (Newbold, 2004). In addition,
grandchildren of DES exposed women reported higher incidences
of rare reproductive disorders; whether this reﬂects detection
bias or possibly implicates a role for epigenetic transgenerational
inheritance remains to be clariﬁed (Newbold, 2004). Ruden et al.
(2005) drawing similarities betweenDES andHsp90 has proposed
a mechanism through which DES establishes altered epigenetic
marks capable of transgenerational inheritance,whereinDESplays
a role in modifying H3K4 methylation by increasing the activity
of theH3K4methyltransferase SMYD3,thereby altering epigenetic
control of various genes.
Animal studies have demonstrated that developmental expo-
sure to BPA can alter epigenetic proﬁles. In agouti mice, Dolinoy
et al. (2007) showed that in utero BPA exposure decreases CpG
methylation and thatmethyl-donor supplementationnegatedBPA
related hypomethylation. In human placental cell lines, BPA expo-
sure has been shown to alter miRNA expression levels (Avissar-
Whiting et al., 2010), and speciﬁcally, miR-146a was strongly
induced by BPA treatment. This resulted in both slower prolif-
eration rate and higher sensitivity to the DNA damaging agent
bleomycin (Avissar-Whiting et al., 2010). BPA, like DES, has also
been shown to alter the methylation status of the Hoxa10 gene in
rodent in utero exposure models (Bromer et al., 2010), and breast
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cancer cell lines exposed to BPA showed altered DNAmethylation
of speciﬁc gene promoters (Weng et al., 2010).
BENZENE
Benzene has been shown to be toxic to hematopoietic systems,
is an established carcinogen (International Agency for Research
on Cancer, 1999), and is known to be a cause of acute myeloid
leukemia (AML) and myelodysplastic syndromes (Ye et al., 2008).
Exposed to low-dose benzene, gasoline attendants and trafﬁc ofﬁ-
cers have demonstrated signiﬁcant leukocyte LINE-1 and Alu
DNA hypomethylation as well as gene speciﬁc hypermethyla-
tion of CDKN2B and hypomethylation of MAGE1(Bollati et al.,
2007).Onepreliminary studyof benzene exposureusingbuffy coat
DNA from six exposed workers and four unexposed workers have
shown some evidence for relatively small changes in methylation
(Zhang et al., 2010). Another preliminary study analyzed miRNA
expression in seven exposed-control matched pairs and identi-
ﬁed upregulated miR-154∗, miR-487a, miR-493-3p, and miR-668
in exposed subjects (Zhang et al., 2010). Additional study of the
potential epigenetic effects of benzene exposure is needed.
RADIATION
Though normally thought to work through DNA damage in the
form of large deletions and in some cases pointmutation (Mcdon-
ald et al., 1995; Little, 2000; Prise et al., 2001), radiation may
also be pathogenic through epigenetic alteration. Silencing of
Cdkn2a was detected in lung tumors of rats induced by expo-
sure to 239plutonium (Swafford et al., 1997). In human lung
adenocarcinoma, CDKN2A methylation occurred more often in
workers compared to non-worker controls of the RussianMAYAK
weapons-grade plutoniumplant, and the prevalence of thismethy-
lation exhibited a dose–response with radiation internal exposure
dose (Belinsky et al., 2004). Methylation of CDKN2A has also
been linked to reactive oxygen species produced by radiation expo-
sures (Romanenko et al., 2002), and murine models of radiation-
induced lymphoma have also demonstrated hypermethylation of
Cdkn2b (encoding p15ink4b (Malumbres et al., 1997, 1999; Cleary
et al., 1999)).
MECHANISMS OF TOXICANT EFFECTS ON EPIGENOMICS
Beyond effects on the one-carbon metabolism pathway, one
must consider other more directed mechanisms through which
toxicants could lead to somatic changes in DNA methyla-
tion, which could be clonally propagated during pathologic
processes. For example altered DNA methylation may be related
to increased reactive oxygen species as a result of inﬂamma-
tory response or as a result of exposure to an ROS produc-
ing toxicant. It has been reported that 5-hydroxymethylcytosine
can be generated by oxidation of 5-methylcytosine (Masuda
et al., 1975), and both 5-methylcytosine adjacent to 8-oxoguanine,
and 5-hydroxymethylcytosine have been shown to inhibit bind-
ing of methyl-CpG binding protein 2, a critical epigenetic
regulator that recruits cytosine methyltransferases and histone
deacetylases (Valinluck et al., 2004). It is also known that 5-
hydroxymethylcytosine is not recognized as 5-methylcytosine by
the maintenance methyltransferase DNMT1, and hence, may lead
to aberrant loss of methylation during cell replication (Valin-
luck and Sowers, 2007). Additional base alterations occur via
neutrophil and eosinophil peroxidase-derived HOCl and HOBr
which can react with DNA to form 5-chlorocytosine and 5-
bromocytosine respectively (Henderson et al., 2003). These halo-
genated cytosines can bemistaken byDNMT1 as 5-methylcytosine
during replication, thus providing a potential mechanism for
inﬂammation-induced aberrant hypermethylation (Valinluck and
Sowers, 2007).
Likely critical to functional epigenetic alterations important
in pathology is the characteristic ability of both mutagenic and
non-mutagenic compounds to impart selective pressures on cel-
lular clones. Some researchers believe that it is this effect, and not
genotoxicity, that provides the carcinogenicity attributable to some
exposures, by selecting pre-existing genetic or possibly epigenetic
alterations (Thilly, 2003). If de novo methylation in the developing
tumor occurred stochastically or due to themechanisms described
above, cells with a silenced tumor suppressor may be selected for
growth or expansion due to exposure to speciﬁc carcinogens. In
time these pressures will allow then for clonal expansion of the
epigenetically altered cells into ﬁelds which now have an increased
susceptibility for tumorigenesis (Slaughter et al., 1953; Wiencke
and Kelsey, 2002).
AGING
The process of aging, and differences in the environment experi-
enced over a lifetime has been hypothesized to inﬂuence clinically
signiﬁcant changes in methylation proﬁles. Aging also provides an
interesting platform to consider additional mechanisms responsi-
ble for altered DNAmethylation patterns. A study of monozygotic
twins demonstrated that young twin-pairs seemed more epige-
netically similar than older monozygotic twins, and suggests that
such drift may be at least in part responsible for differences in
disease susceptibility (Fraga et al., 2005). Motivated by studies
of methylation in cancer, an early report from Issa et al. (1994)
described an association between aging colonic mucosa and estro-
gen receptor methylation. This type of research has been extended
more recently to show an overall trend of increased methylation
associated with older age in normal human prostate and colon
tissues in several genes (Shen et al., 2005; Kwabi-Addo et al.,
2007). Although an increase in promoter methylation with aging
is generally accepted, and is consistent with hypermethylation
of tumor suppressor genes in cancer, a disease of aging, recent
evidence fromBjornsson et al. (2008) suggests amore complexpic-
ture. These authors measured intra-individual global methylation
changes over >10 years and found both increased and decreased
methylation levels dependent on the individual, with over 50% of
participants exhibiting >5% change in methylation in peripheral
blood cell DNA over time.
A study of over 200 non-pathologic human tissues from 10
anatomic sites using the GoldenGate methylation array platform
(1413 autosomal CpG loci) demonstrated consistent associations
between methylation and age at previously reported candidate
genes, and in conjunction with other reports, suggested that the
relation between aging and promoter CpG methylation is com-
plex (Christensen et al., 2009b). The direction and strength of
correlation between age and methylation were largely dependent
upon CpG-island status. Speciﬁcally, a propensity for CpG-island
loci to gain methylation with age, and non-island CpGs to lose
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methylation with age was found. These results were consistent
with (Issa, 2003; Shen et al., 2005; Kwabi-Addo et al., 2007), as well
as with the ﬁndings of Tra et al. (2002) and Bjornsson et al. who
showed bi-modal age-relatedmethylation in normal tissues. Using
restriction-landmark genome scanning of over 2000 CpG loci in T
lymphocytes comparingnewborns,middle age, and elderly people,
reported that 29 loci had age-related methylation alterations, with
23 loci displaying increased methylation with age and six decreas-
ing with age. In addition Teschendorff et al. (2010) have suggested
that age-dependent methylation of polycomb-group target genes
(genes suppressed in stem cells allowing differentiation) is a hall-
mark of cancer and is independent of gender, tissue type, or
disease state, suggesting a mechanism for aging to predispose to
carcinogenesis.
ADDITIONAL MECHANISTIC CONSIDERATIONS
The observed pattern of age associated methylation in (Chris-
tensen et al.,2009b)was also irrespective of tissue type, suggesting a
commonmechanism or dysregulation to explain these alterations.
Langevin et al. (2011) expanded these analyses to the larger, Illu-
mina Inﬁnium Methylation27 platform, assessing nearly 27,000
autosomal CpG loci in peripheral blood samples of healthy adults,
and found again that the direction and magnitude of the associa-
tion between methylation at CpG site and age was inﬂuenced by
local sequence features. In addition, the study from Christensen
et al. (2009b) that examined non-pathologic tissue methylation
assessed different exposure types in different tissues. Though a
detailed analysis that included genomic context was not published,
these authors observed a consistent trend for exposure-related
methylation alterations across tissue types. Assessment of pleural
tissue methylation by asbestos exposure history, lung tissue by
smoking history, and peripheral blood methylation by alcohol
intake each indicated that exposure-associated methylation alter-
ations were dependent on genomic context for CpGs analyzed.
However, unlike age-related methylation alterations (increased
methylation of CpG-island loci with age, and decreased methy-
lation of non-CpG-island loci with age) exposure-related methy-
lation alterations each had a contrasting pattern where CpG-
island loci decreased with exposure, and non-CpG-island loci
had increased methylation with exposure (unpublished). These
reports highlight the importance of recognizing that contextual
elements may differentially affect the likelihood and direction
of exposure-related epigenetic alterations. Though these ﬁndings
suggest that different mechanisms are responsible for age-related
and exposure-relatedmethylation alterations, and that some expo-
sures may share common mechanisms for altering methylation,
additional population-based research on appropriate target tissues
is necessary to advance our understanding of any shared (within
and across exposure types) or disparate mechanisms responsible
for methylation alterations.
Beyond sequence context, one may also consider the chro-
matin environment to understand regions targeted for alterations
of DNA methylation. Rakyan et al. (2010) showed that aging-
associated hypermethylation was more likely to occur at pro-
moters associated with bivalent chromatin domains. Additionally,
distinct mechanisms may be responsible for altered repeat ele-
ment (global) methylation and altered promoter methylation.
Although traditional dogma indicates separate methyltransferase
enzymes for maintenance (DNMT1) and de novo methylation
(DNMT3A/B), a recent perspective from Jones and Liang (2009)
proposes that maintenance methylation in CpG-islands may be a
cooperative process. When considering the mechanisms of envi-
ronmental exposure-related methylation alterations it is impor-
tant to remain conscious of the fact that we do not have a
complete understanding of de novo and maintenance methylation
mechanisms. Reduced ﬁdelity of maintenance methyltransferases
with aging is one potential explanation for age-related decreases
in methylation; while age-related increases in methylation could
potentially reﬂect the accumulation of stochastic methylation
events over time. Another mechanism that has been hypothesized
is a spreading process, whereby CpG methylation from within
the gene migrates into the promoter due to the loss of protec-
tive boundary elements which normally protect promoters from
CpG-island methylation (Turker and Bestor, 1997; Sun and Elgin,
1999; Turker, 2002). Alternatively, for example in aging, a spread-
ing process subsequent to a stochastic methylation alteration (in
pathologically normal tissue)without functional consequences for
gene expression, may allow the initiation of a spreading process
that eventually confers an altered expression phenotype. Yet, these
mechanisms do not fully explain the apparently sequence context
speciﬁcity of these observations, thereby suggesting that the age-
related alterations of methylation observed may be inﬂuence in
part by targeted mechanisms that have yet to be fully explained.
Using long-term culture of mesenchymal stem cells, Bork et al.
(2010) show that for the majority of CpGs examined (using the
Illumina Inﬁnium Methylation27 platform), the methylation lev-
els remain constant, and that only a speciﬁc set of CpGs undergo
differential methylation with long-term culture, and that these
sites were over-represented by homeobox genes. This same group
(Koch et al., 2011) demonstrated similar ﬁndings in aging dermal
ﬁbroblasts, although often in directions opposite those observed
in theMSCs. Such results suggest that aging related DNAmethyla-
tion may be following a developmental program or resulting from
the loss of some developmentally regulated maintenance.
IMPORTANCE OF EPIGENOMICS IN ENVIRONMENTAL
HEALTH
Wehave highlightedwhat is a growing body of literature beginning
to link epigenetic alterations to toxicant exposures from in vitro
work, animal models, and human observational studies. Toxicol-
ogists and environmental health scientists, in addition to studying
the effects of exposures at the genotoxic and transcriptional lev-
els, must also consider a toxicants effect on the epigenome, a task
which requires multi-disciplinary work from in vitro and model
systems to epidemiologic studies of human disease. New technolo-
gies now allow for global analysis of epigenetic alterations and
these may provide insight into the extent and patterns of alter-
ation in normal and diseased tissue. Notably, the latest generation
of CpG methylation arrays interrogates hundreds of thousands
of CpG loci, includes all designable RefSeq genes, and is low-cost
enough for application in population-level studies. Next genera-
tion sequencing approaches, as their cost decreases and through-
put increases will also become increasingly used as tools for anno-
tating the epigenome and its relation to exposures. Appropriate
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models must also be considered, and may include mammalian
stem cells which could prove extremely useful in bettering the
understanding of epigenetics in development and beyond. Finally,
epidemiologist must begin to consider how to incorporate exam-
inations of the epigenome in population-based studies, in order
to deﬁne consistent methodologies and data collection that is cru-
cial to understanding the true effect of environmental exposures
on the human epigenome. Although examinations of epigenetic
alterations related to exposures are emerging it is still important
to note that the mechanisms by which toxicants and the environ-
ment modulate the epigenetic landscape of individual cells are
yet to be elucidated and require further exploration. This work
is urgently needed in order to better understand the biology of
epigenetic alterations and the effects of toxic exposures on these
disease-associated somatic epigenetic alterations. Better deﬁned
mechanisms will lead to better prediction of the toxic potential of
new compounds introduced into the environment, and allow for
more targeted and appropriate disease prevention strategies.
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